Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BEN GREGORY BOSTICK

Allopathic & Osteopathic Physicians Family Medicine

NPI
1518948215
CMS profile
250751
Location
CULLMAN, AL

General Payments · PY2018–2024

$7,720.99

  • Reported across 384 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$283.59

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $283.59 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,063.54 100
PY2019 $1,092.77 71
PY2020 $979.27 60
PY2021 $778.10 47
PY2022 $728.71 46
PY2023 $795.01 44
PY2024 $283.59 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $22.15 05/15/2024 Food and Beverage Undisputed 01/23/2026 1111533830 CMS
AstraZeneca Pharmaceuticals LP $13.67 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104667247 CMS
AstraZeneca Pharmaceuticals LP $14.85 08/07/2024 Food and Beverage Undisputed 01/23/2026 1105417472 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.50 07/16/2024 Food and Beverage Undisputed 01/23/2026 1086178660 CMS
Dexcom, Inc. $17.42 01/10/2024 Food and Beverage Undisputed 01/23/2026 1153285415 CMS
Exact Sciences Corporation $14.12 10/29/2024 Food and Beverage Undisputed 01/23/2026 1114596509 CMS
Lilly USA, LLC $18.72 11/06/2024 Food and Beverage Undisputed 01/23/2026 1136064586 CMS
Lundbeck LLC $15.58 12/09/2024 Food and Beverage Undisputed 01/23/2026 1145899220 CMS
Novartis Pharmaceuticals Corporation $17.97 02/22/2024 Food and Beverage Undisputed 01/23/2026 1086677729 CMS
Novo Nordisk Inc $17.91 02/01/2024 Food and Beverage Undisputed 01/23/2026 1097068989 CMS
Novo Nordisk Inc $20.38 04/17/2024 Food and Beverage Undisputed 01/23/2026 1096808609 CMS
Novo Nordisk Inc $18.02 05/21/2024 Food and Beverage Undisputed 01/23/2026 1096795971 CMS
Novo Nordisk Inc $25.53 11/21/2024 Food and Beverage Undisputed 01/23/2026 1097180723 CMS
PFIZER INC. $20.21 06/27/2024 Food and Beverage Undisputed 01/23/2026 1131677712 CMS
PFIZER INC. $18.15 10/23/2024 Food and Beverage Undisputed 01/23/2026 1131938775 CMS
Phathom Pharmaceuticals, Inc. $14.41 01/23/2024 Food and Beverage Undisputed 01/23/2026 1151042149 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.